Tech Company Financing Transactions
ArcherDX Funding Round
On 5/16/2019, ArcherDX raised $60 million in Series B funding from Perceptive Advisors, Boulder Ventures and Longwood Fund.
Transaction Overview
Company Name
Announced On
5/16/2019
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Series B
Investors
Perceptive Advisors (Lead Investor) (Sam Chawla)
Boulder Ventures (Kyle Lefkoff)
Proceeds Purpose
Proceeds from the financing are planned to be used to scale operations and advance the company's companion diagnostic program that spans solid tumors, hematological malignancies and circulating tumor DNA (ctDNA) applications.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2477 55th St. 202
Boulder, CO 80301
USA
Boulder, CO 80301
USA
Phone
Website
Email Address
Overview
ArcherDX addresses the bottlenecks associated with using NGS in translational research by offering a robust platform for targeted sequencing applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jason Myers
Chief Medical Officer
Todd Druley
Chief Scientific Officer
Josh Stahl
VP - Bus. Development
Matthew Franklin
VP - General Counsel
Benjamin Carver
VP - Human Resources
Karen Fritschen
VP - Operations
Richard Sjogren
VP - Regulatory Affairs
Sandra Close
Browse more venture capital transactions:
Prev: 5/16/2019: KOHO Financial venture capital transaction
Next: 5/16/2019: Novi venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document every notable VC transaction. VC investment data records reported here are derived from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs